Physician profile
Violeta Lizano
NPI 1164583613
$586.04
in general payments reported to CMS, 2019-2025
11 companies · $37.54 in 2025
The $37.54 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $184 · 2020: $44.11 · 2021: $110 · 2022: $132 · 2023: $45.85 · 2024: $33.39 · 2025: $37.54.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $117.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $116.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $228.01 | 2019-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $133.97 | 2019-2022 | |
| Sanofi Pasteur INC. | $45.18 | 2019-2020 | |
| Glaxosmithkline, LLC. | $41.05 | 2022 | |
| Abiomed | $37.54 | 2025 | |
| Janssen Biotech, INC. | $25.37 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $22.11 | 2021 | |
| Qol Medical, LLC | $16.56 | 2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $13.40 | 2019 | |
| Intercept Pharmaceuticals, INC. | $11.93 | 2019 | |
| Endogastric Solutions, INC | $10.92 | 2024 | Esophyx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Violeta Lizano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.